TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Grant Support/Research Contract (Institutional) - Abiomed; Ancora
• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Corvia; BackBeat Medical; Impulse Dynamics; Zoll; Bayer AG; AquaPass; CardioDyme; BioMind
• Equity/Stock(s)/Options (Personal) - PVLoops LLC